Current and historical daily PE Ratio for ROIV (
Roivant Sciences Ltd
) from 2021 to May 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Roivant Sciences stock (ROIV) PE ratio as of May 20 2024 is 2.16.
More Details
Roivant Sciences Ltd (ROIV) PE Ratio (TTM) Chart
Roivant Sciences Ltd (ROIV) PE Ratio (TTM) Historical Data
View and export this data going back to 2021. Start your Free Trial
Total 661
- 1
- 2
- 3
- 4
- 5
- 6
- 8
| Roivant Sciences PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-20 | 2.2 | 2024-03-15 | 1.9 |
| 2024-05-17 | 2.2 | 2024-03-14 | 2.0 |
| 2024-05-16 | 2.2 | 2024-03-13 | 2.0 |
| 2024-05-15 | 2.2 | 2024-03-12 | 2.0 |
| 2024-05-14 | 2.2 | 2024-03-11 | 2.0 |
| 2024-05-13 | 2.1 | 2024-03-08 | 2.0 |
| 2024-05-10 | 2.1 | 2024-03-07 | 2.1 |
| 2024-05-09 | 2.2 | 2024-03-06 | 2.2 |
| 2024-05-08 | 2.2 | 2024-03-05 | 2.2 |
| 2024-05-07 | 2.2 | 2024-03-04 | 2.2 |
| 2024-05-06 | 2.2 | 2024-03-01 | 2.3 |
| 2024-05-03 | 2.2 | 2024-02-29 | 2.2 |
| 2024-05-02 | 2.2 | 2024-02-28 | 2.3 |
| 2024-05-01 | 2.2 | 2024-02-27 | 2.3 |
| 2024-04-30 | 2.1 | 2024-02-26 | 2.3 |
| 2024-04-29 | 2.1 | 2024-02-23 | 2.2 |
| 2024-04-26 | 2.1 | 2024-02-22 | 2.2 |
| 2024-04-25 | 2.1 | 2024-02-21 | 2.2 |
| 2024-04-24 | 2.1 | 2024-02-20 | 2.2 |
| 2024-04-23 | 2.1 | 2024-02-16 | 2.2 |
| 2024-04-22 | 2.0 | 2024-02-15 | 2.2 |
| 2024-04-19 | 2.0 | 2024-02-14 | 2.2 |
| 2024-04-18 | 2.0 | 2024-02-13 | 2.1 |
| 2024-04-17 | 2.0 | 2024-02-12 | 2.1 |
| 2024-04-16 | 2.1 | 2024-02-09 | 2.1 |
| 2024-04-15 | 2.1 | 2024-02-08 | 2.0 |
| 2024-04-12 | 2.1 | 2024-02-07 | 2.0 |
| 2024-04-11 | 2.1 | 2024-02-06 | 2.0 |
| 2024-04-10 | 2.1 | 2024-02-05 | 1.9 |
| 2024-04-09 | 2.2 | 2024-02-02 | 1.9 |
| 2024-04-08 | 2.2 | 2024-02-01 | 1.9 |
| 2024-04-05 | 2.3 | 2024-01-31 | 1.9 |
| 2024-04-04 | 2.2 | 2024-01-30 | 2.0 |
| 2024-04-03 | 2.2 | 2024-01-29 | 2.0 |
| 2024-04-02 | 2.1 | 2024-01-26 | 2.0 |
| 2024-04-01 | 2.0 | 2024-01-25 | 2.0 |
| 2024-03-28 | 2.0 | 2024-01-24 | 2.0 |
| 2024-03-27 | 2.1 | 2024-01-23 | 2.0 |
| 2024-03-26 | 1.9 | 2024-01-22 | 2.0 |
| 2024-03-25 | 1.9 | 2024-01-19 | 2.0 |
| 2024-03-22 | 1.9 | 2024-01-18 | 2.0 |
| 2024-03-21 | 2.0 | 2024-01-17 | 2.1 |
| 2024-03-20 | 1.9 | 2024-01-16 | 2.1 |
| 2024-03-19 | 1.9 | 2024-01-12 | 2.1 |
| 2024-03-18 | 1.9 | 2024-01-11 | 2.1 |
Roivant Sciences Ltd (ROIV) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Roivant Sciences Ltd
ISIN : BMG762791017
Share Class Description:
ROIV: Ordinary SharesDescription
Roivant Sciences Ltd is a biopharmaceutical company dedicated to improving the delivery of healthcare to patients.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers